Medical Developments International Ltd (MVP)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Medical Developments International Ltd (MVP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013335
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company’s products include penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products which include autoclavable space chamber breath alert peak flow meter, compact space chamber, disposable face mask, MDI silicone face mask and others. MDI offers medical devices which include CPR face shield key ring, CPR mask, CPR resuscitation pocket mask, finger pulse oximeter and hudson mask with reservoir bag. The company operates manufacturing facilities located in Victoria. It also operates in Canada and the UK. MDI is headquartered in Melbourne, Victoria, Australia.

Medical Developments International Ltd (MVP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medical Developments International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medical Developments International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
JSC Lancet Enters into Licensing Agreement with Medical Developments International for Penthrox 11
Purdue Pharma Enters into Licensing Agreement with Medical Developments 12
Medical Developments to Enter into Licensing Agreement for Penthrox in Canada 13
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 14
Medical Developments International Plans to Enter into Licensing Agreement for Penthrox 15
Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 16
Medical Developments International Ltd – Key Competitors 17
Medical Developments International Ltd – Key Employees 18
Medical Developments International Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 20
Other Significant Developments 21
Feb 05, 2016: Avita Medical Completes Sale of Respiratory Business for $2.47m 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medical Developments International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medical Developments International Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Medical Developments International Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Medical Developments International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
JSC Lancet Enters into Licensing Agreement with Medical Developments International for Penthrox 11
Purdue Pharma Enters into Licensing Agreement with Medical Developments 12
Medical Developments to Enter into Licensing Agreement for Penthrox in Canada 13
Mundipharma Enters into Licensing Agreement with Medical Developments for Penthrox 14
Medical Developments International Plans to Enter into Licensing Agreement for Penthrox 15
Galen Enters into Licensing Agreement with Medical Developments International for Penthrox 16
Medical Developments International Ltd, Key Competitors 17
Medical Developments International Ltd, Key Employees 18

★海外企業調査レポート[Medical Developments International Ltd (MVP)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DURECT Corp (DRRX):医療機器:M&Aディール及び事業提携情報
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Mmi Holdings Ltd.:企業の戦略・SWOT・財務分析
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sellier & Bellot J.S.C.:企業の戦略・SWOT・財務情報
    Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Sellier & Bellot J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kian Joo Can Factory Berhad:企業の戦略・SWOT・財務情報
    Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report Summary Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China Overseas Land & Investment Limited:企業の戦略・SWOT・財務情報
    China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report Summary China Overseas Land & Investment Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • BioMedomics Inc-医療機器分野:企業M&A・提携分析
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platfo …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lite-On Technology Corp (2301):企業の財務・戦略的SWOT分析
    Lite-On Technology Corp (2301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Idemitsu Kosan Co Ltd (5019)-エネルギー分野:企業M&A・提携分析
    Summary Idemitsu Kosan Co., Ltd. (Idemitsu) is an integrated energy company that explores, produces, refines, and sells oil and gas, lubricants, and petroleum products. Apart from petroleum products, the company also manufactures agricultural chemicals, agricultural materials, and other chemicals. I …
  • Imagion Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Imagion Biosystems Inc (Imagion Biosystems), formerly Senior Scientific LLC, a subsidiary of Manhattan Scientifics Inc, is a biomedical equipment provider that offers nanomagnetic particle detection systems. The company offers nanomagnetic relaxometry method for cancer detection and precisio …
  • The Walsh Group Ltd:企業の戦略的SWOT分析
    The Walsh Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Nanotech Security Corp.:企業の戦略・SWOT・財務情報
    Nanotech Security Corp. - Strategy, SWOT and Corporate Finance Report Summary Nanotech Security Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • ONEOK Partners LP (OKS)-石油・ガス分野:企業M&A・提携分析
    Summary ONEOK Partners, L.P. (ONEOK Partners), a subsidiary of Oneok, Inc., is a midstream energy company. The company carries out gathering, processing, and storage and transportation of natural gas. It operates through master limited partnerships. ONEK Partners owns natural gas liquids (NGL) syste …
  • Protonex Technology Corporation:電力:M&Aディール及び事業提携情報
    Summary Protonex Technology Corporation (Protonex) is a fuel cell company, which carries out research, development and production of a wide range of power solutions. It principally offers advanced fuel cell power solutions for portable, remote and mobile applications. The company produces these prod …
  • Valero Energy Corporation (VLO)-石油・ガス分野:企業M&A・提携分析
    Summary Valero Energy Corporation (Valero) is a manufacturer and marketer of transportation fuels, petrochemical products and power. The company’s assets include petroleum refineries, ethanol plants, a wind farm and renewable diesel production from a joint venture. Its refineries produce gasoline, d …
  • Trident Limited:戦略・SWOT・企業財務分析
    Trident Limited - Strategy, SWOT and Corporate Finance Report Summary Trident Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆